Nephrocare Health Services Limited (NSE:NEPHROPLUS)
India · Delayed Price · Currency is INR 628.80
-6.90 (-1.09%)
At close: Jul 20, 2026
Nephrocare Health Services Earnings Call Transcripts
Fiscal Year 2026
-
Revenue grew 32% YoY to INR 998.8 crore, with adjusted EBITDA up 37% and PAT up 75%, driven by international expansion and operational leverage. RPT rose 13.3% to INR 2,598, and ROCE improved to 22.8%. Guidance remains at 15%-20% CAGR over 3-4 years.
-
Revenue grew 32% YoY in Q3 and 37% for nine months FY 2026, with international business now 41% of revenue. Adjusted EBITDA margin rose to 24.3%, and ROCE is projected to reach 24.7%. Guidance is for 15%-20% revenue CAGR over 3-4 years.